Sponsored by
AIHealthTech Insider: Issue # 101
May 18, 2026
Three FDA-level stories. One Harvard study that's harder to dismiss than usual. And a coffee finding that might change your morning.
Summaries are for education, not medical advice. Always verify locally before clinical use.
🔬 The Big Story
An AI just decided who needs chemo — and who doesn't.
On May 12, the FDA cleared ArteraAI Breast — the first AI ever authorized to help guide breast cancer chemotherapy decisions.
Image: AI-generated, AIHealthTech Insider
It reads digital pathology slides for women with early-stage HR+/HER2- breast cancer — the most common type and sorts them into low-risk or high-risk.
In a cohort of 12,000 patients, the AI identified 68% as low-risk — with an estimated 10-year distant metastasis-free survival of approximately 95%. Women in that group got essentially no added benefit from chemo.
Translation: thousands of women may finally be spared chemotherapy they never needed.
But here's what nobody's saying out loud — this is the first time the FDA has cleared an AI to influence a treatment decision this consequential. Not a triage flag. A direct input into do you do chemo or not.
What happens the first time the AI says skip and the cancer comes back?
That question hasn't been answered yet.
New here? This is AIHealthTech Insider — AI healthcare signals every week, plain English, no jargon. Subscribe free below.
Sponsored
Your Website Shouldn't Look Like It Was AI-Generated
You know the pain. Your AI builder ships something functional. Technically a website. But your customers can tell.
Readdy.ai generates designs that actually convert, with clean layouts, professional copy, real visual hierarchy, and distinct custom designs that don't look like AI.
Get a site that's as special as your business. Live in under 5 minutes.
Agency quality. DIY price.
⚡ Quick Hits
🔸Harvard tested AI against ER doctors. The AI won.
OpenAI's o1 model got the right diagnosis 67% of the time on real ER cases. The doctors? 55% and 50%.
Image: AI-generated, AIHealthTech Insider
Published in Science on May 3. The researchers didn't even clean the data — the AI got the same messy electronic records the doctors did.
One co-author admitted: "We're already at the ceiling."
There's a catch the headlines are skipping over.
🔸The AI 40% of U.S. physicians use just got smarter — and patients still don't know it exists
It's called OpenEvidence. According to the company, it's used daily by over 40% of U.S. physicians, across more than 10,000 hospitals. NBC found doctors from Hawaii to Maine quietly running clinical questions through it, most patients have no idea.
Image source: OpenEvidence
On May 11, it got a major upgrade. The Society of Surgical Oncology — the global professional body for cancer surgeons signed a strategic partnership giving OpenEvidence direct access to its clinical guidelines and educational content. That now stacks on top of existing deals with NEJM, JAMA, NCCN, Wiley, and Cochrane.
Translation: when your surgeon checks the AI before your operation, it's pulling from the same playbook the world's top cancer surgeons wrote.
But there's one thing the press release isn't saying about who's actually paying for all this access.
🔸Medicare just opened the door for AI to compete for federal patients
On July 5, a 10-year CMS program called ACCESS goes live. Outcome-based payments. Conditions covered: diabetes, hypertension, kidney disease, obesity, musculoskeletal pain, depression, and anxiety
Image: AI-generated, AIHealthTech Insider
Translation: the federal government is paying AI companies to manage real patients — and only paying full price if those patients actually get healthier.
The risk no one's loudly discussing involves your most sensitive medical data.
Know someone in healthcare, medicine, or AI? Forward this to them. They can subscribe free here →
🌍 Beyond AI
Your coffee habit may be doing more for your brain than you think.
A JAMA study published May 13 followed 131,821 people for over four decades. Those in the highest quartile of caffeinated coffee intake had an 18% lower risk of dementia compared to those who drank little or none.
Image: AI-generated, AIHealthTech Insider
But more wasn't better. The protective effect plateaued. And no protective association was found for decaf, suggesting caffeine itself is doing the work.
Two cups. Not five.
Sponsored
10x the context. Half the time.
Speak your prompts into ChatGPT or Claude and get detailed, paste-ready input that actually gives you useful output. Wispr Flow captures what you'd cut when typing. Free on Mac, Windows, and iPhone.
📊 Stat of the Week
$4 billion — what digital health startups raised in Q1 2026 alone.
The detail that matters more: Rock Health, which has tracked digital health funding for over a decade, is retiring its "AI deal" category. AI is now so embedded in every healthcare deal that it can't be isolated as a trackable subset anymore.
When the trackers stop tracking, the wave already broke.
🐰 Rabbit Hole
Two links worth falling into this week:
Hospitals run on a 1% margin. A startup just raised $27M to give every hospital its own AI CFO. → Fortune
Insilico just released an AI agent that runs drug discovery experiments on its own. No coding required. → pharmaphorum
💼 Who's Hiring
Medical AI Trainer (Remote · Part-Time · Flexible) — Outlier AI hires MDs, DOs, MBBS, currently-enrolled med students, NPs, and PAs to evaluate AI model responses for clinical accuracy. Work your own hours, earn around $1,500/week if active. No coding required. → Apply
Clinical Informaticist I — ECU Health · Greenville, NC Translate clinical workflows into AI, telehealth, and EHR specifications. Entry-level path into healthcare AI for nurses, allied health pros, and clinicians with hospital experience. Requirements: associate degree or higher in a clinical discipline, 2 years of EHR experience. No advanced tech degree required. → Apply
Clinical AI Product Specialist — Hippocratic AI · Palo Alto, CA — Help shape the world's first healthcare-only generative AI platform. Clinical experience in acute, ambulatory, telehealth, or community settings; strong patient communication skills. Open to nurses, PAs, NPs, and other licensed clinicians moving into AI product work. → Apply
💡 The One Thing
An AI now helps decide who needs chemo. Over 40% of U.S. physicians quietly run patient questions through an AI you've never heard of. And the federal government just opened the door for AI to compete for Medicare patients.
The pattern is the same every week: AI is being woven deeper into clinical decisions while patients hear about it last, if at all.
That's why this newsletter exists.
Image: AI-generated, AIHealthTech Insider
One question before you go:
If an AI told you that you could safely skip chemotherapy, would you trust it?
Stay ahead: AI Healthcare News!
This is just a glimpse of the AI healthcare revolution. Subscribe for exclusive updates on medicine’s future!
